106 related articles for article (PubMed ID: 9704054)
1. Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases.
Nano R; Barni S; Gerzeli G; Pinelli T; Altieri S; Fossati F; Prati U; Roveda L; Zonta A
Ann N Y Acad Sci; 1997 Dec; 832():274-8. PubMed ID: 9704054
[No Abstract] [Full Text] [Related]
2. Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma: optical and ultrastructural study in the rat.
Nano R; Barni S; Chiari P; Pinelli T; Fossati F; Altieri S; Zonta C; Prati U; Roveda L; Zonta A
Oncol Rep; 2004 Jan; 11(1):149-53. PubMed ID: 14654918
[TBL] [Abstract][Full Text] [Related]
3. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
Dagrosa MA; Crivello M; Perona M; Thorp S; Santa Cruz GA; Pozzi E; Casal M; Thomasz L; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):262-8. PubMed ID: 20932650
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
[TBL] [Abstract][Full Text] [Related]
5. Boron biodistribution study in colorectal liver metastases patients in Argentina.
Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931
[TBL] [Abstract][Full Text] [Related]
6. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
Wittig A; Collette L; Moss R; Sauerwein WA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for murine malignant gliomas.
Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
[TBL] [Abstract][Full Text] [Related]
8. Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned.
Zonta A; Pinelli T; Prati U; Roveda L; Ferrari C; Clerici AM; Zonta C; Mazzini G; Dionigi P; Altieri S; Bortolussi S; Bruschi P; Fossati F
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S67-75. PubMed ID: 19394837
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy.
Ishiwata K; Ido T; Mejia AA; Ichihashi M; Mishima Y
Int J Rad Appl Instrum A; 1991; 42(4):325-8. PubMed ID: 1850716
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
11. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
12. The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster.
Hiratsuka J; Fukuda H; Kobayashi T; Karashima H; Yoshino K; Imajo Y; Mishima Y
Radiat Res; 1991 Nov; 128(2):186-91. PubMed ID: 1947014
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
Coderre JA; Slatkin DN; Micca PL; Ciallella JR
Radiat Res; 1991 Nov; 128(2):177-85. PubMed ID: 1947013
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy for cancer.
Barth RF; Soloway AH; Fairchild RG
Sci Am; 1990 Oct; 263(4):100-3, 106-7. PubMed ID: 2173134
[No Abstract] [Full Text] [Related]
15. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
16. [Neutron capturing irradiation: principle, current results and perspectives].
Pignol JP; Chauvel P
Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
[TBL] [Abstract][Full Text] [Related]
17. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
18. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
19. Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation.
Ichihashi M; Nakanishi T; Mishima Y
J Invest Dermatol; 1982 Mar; 78(3):215-8. PubMed ID: 7057053
[TBL] [Abstract][Full Text] [Related]
20. In vitro radiobiological analysis of 10B-L-BPA for BNCT of malignant melanoma: correlation of determined 10B-content and cell killing effect.
Ichihashi M; Shiono M; Yamamura K; Komura A; Mishima Y; Yoshino K; Hori Y
Pigment Cell Res; 1992; Suppl 2():193-8. PubMed ID: 1409422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
